Donor BMI and Post-living Donor Liver Transplantation Outcomes: A Preliminary Report

被引:7
|
作者
Lin, Jessica S. [1 ]
Muhammad, Haris [1 ]
Lin, Timothy [2 ]
Kemel, Ihab [3 ]
Baghdadi, Azarakhsh [3 ]
Rizkalla, Nicole [4 ]
Ottmann, Shane E. [5 ]
Wesson, Russell [5 ]
Philosophe, Benjamin [5 ]
Gurakar, Ahmet [2 ]
机构
[1] Johns Hopkins Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Radiat Oncol, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Radiol, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Dept Anesthesia, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Dept Surg, Div Transplant Surg, Sch Med, Baltimore, MD USA
来源
TRANSPLANTATION DIRECT | 2023年 / 9卷 / 02期
关键词
BODY-MASS INDEX; HEPATIC STEATOSIS; QUANTIFICATION;
D O I
10.1097/TXD.0000000000001431
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background.Living liver donor obesity has been considered a relative contraindication to living donation given the association with hepatic steatosis and potential for poor donor and recipient outcomes. We investigated the association between donor body mass index (BMI) and donor and recipient posttransplant outcomes. Methods.We studied 66 living donors and their recipients who underwent living donor liver transplant at our center between 2013 and 2020. BMI was divided into 3 categories (<25, 25-29.9, and >= 30 kg/m(2)). Magnetic resonance imaging-derived proton density fat fraction was used to quantify steatosis. Donor outcomes included length of stay (LOS), emergency department visits within 90 d, hospital readmissions within 90 d, and complication severity. Recipient outcomes included LOS and in-hospital mortality. The Student t test was used to compare normally distributed variables, and Kruskal-Wallis tests were used for nonparametric data. Results.There was no difference in donor or recipient characteristics based on donor BMI. There was no significant difference in mean magnetic resonance imaging fat percentage among the 3 groups. Additionally, there was no difference in donor LOS (P = 0.058), emergency department visits (P = 0.64), and hospital readmissions (P = 0.66) across BMI category. Donor complications occurred in 30 patients. There was no difference in postdonation complications across BMI category (P = 0.19); however, there was a difference in wound complications, with the highest rate being seen in the highest BMI group (0% versus 16% versus 37%; P = 0.041). Finally, there was no difference in recipient LOS (P = 0.83) and recipient in-hospital mortality (P = 0.29) across BMI category. Conclusions.Selecting donors with BMI >= 30 kg/m(2) can result in successful living donor liver transplantation; however, they are at risk for perioperative wound complications. Donor counseling and perioperative strategies to mitigate wound-related issues should be used when considering obese living donors.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Living donor liver transplantation for obese patients: Challenges and outcomes
    Gunay, Yusuf
    Guler, Necdet
    Dayangac, Murat
    Taskesen, Fatih
    Yaprak, Onur
    Emek, Ertan
    Akyildiz, Murat
    Altaca, Gulum
    Yuzer, Yildiray
    Tokat, Yaman
    LIVER TRANSPLANTATION, 2014, 20 (03) : 311 - 322
  • [2] Donor Liver Attenuation Index and Liver Biopsy Correlation in Living Donor Liver Transplantation
    Latif, A. M. E. R.
    Naz, S. U. M. B. U. L.
    Naseer, F. A. I. S. A. L.
    Alam, H. U. M. A. I. R. A.
    Bhatti, Muhammad Afzal
    Ashraf, S. H. A. H. Z. A. D.
    Rana, Muhammad Asim
    Hafeez, Muhammad Mansoor
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (07): : 1772 - 1775
  • [3] Aborted donor hepatectomy in living donor liver transplantation: lessons learned
    Kutluturk, K.
    Akbulut, S.
    Baskiran, A.
    Gonultas, F.
    Dirican, A.
    Isik, B.
    Yilmaz, S.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2020, 58 (02) : 91 - 100
  • [4] Treatment of Rapid Weight Loss in a Donor with Hepatic Steatosis in Living Donor Liver Transplantation: A Case Report
    Yamanaka-Okumura, Hisami
    Urano, Eri
    Kawaura, Akihiko
    Imura, Satoru
    Utsunomiya, Tohru
    Shimada, Mitsuo
    Takeda, Eiji
    HEPATO-GASTROENTEROLOGY, 2012, 59 (115) : 869 - 871
  • [5] Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation
    Moghe, Akshata
    Ganesh, Swaytha
    Humar, Abhinav
    Molinari, Michele
    Jonassaint, Naudia
    CLINICS IN LIVER DISEASE, 2021, 25 (01) : 121 - 135
  • [6] Living Donor Liver Transplantation: The Asian Perspective
    Cheng, Yu-Fan
    Yu, Chun-Yen
    Ou, Hsin-You
    Tsang, Leo Leung-Chit
    Huang, Tung-Liang
    Chen, Tai-Yi
    Concejero, Allan
    Wang, Chih-Chi
    Wang, Shih-Ho
    Lin, Tsan-Shiun
    Liu, Yueh-Wei
    Yang, Chin-Hsiang
    Yong, Chee-Chien
    Chiu, King-Wah
    Jawan, Bruno
    Eng, Hock-Liew
    Chen, Chao-Long
    TRANSPLANTATION, 2014, 97 (08) : S3 - S6
  • [7] Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation
    Kamo, Naoko
    Kaido, Toshimi
    Hamaguchi, Yuhei
    Okumura, Shinya
    Kobayashi, Atsushi
    Shirai, Hisaya
    Yao, Siyuan
    Yagi, Shintaro
    Uemoto, Shinji
    CLINICAL NUTRITION, 2019, 38 (05) : 2202 - 2209
  • [8] The diminishing role of liver biopsy in living donor liver transplantation
    Trotter, James F.
    LIVER TRANSPLANTATION, 2018, 24 (04) : 457 - 458
  • [9] Severe post-transplant lymphoproliferative disorder after living donor liver transplantation
    Kuramitsu, Kaori
    Fukumoto, Takumi
    Fukushima, Kenji
    Iwasaki, Takeshi
    Tominaga, Masahiro
    Matsui, Toshimitsu
    Kawakami, Fumi
    Itoh, Tomoo
    Ku, Yonson
    HEPATOLOGY RESEARCH, 2015, 45 (03) : 356 - 362
  • [10] Nonalcoholic steatohepatitis in donors for living donor liver transplantation
    Yamamoto, Koji
    Takada, Yasutsugu
    Fujimoto, Yasuhiro
    Haga, Hironori
    Oike, Fumitaka
    Kobayashi, Nobuaki
    Tanaka, Koichi
    TRANSPLANTATION, 2007, 83 (03) : 257 - 262